CNP (1-22), human
CAS No. 127869-51-6
CNP (1-22), human( —— )
Catalog No. M29886 CAS No. 127869-51-6
C-Type Natriuretic Peptide (CNP) (1-22), human is the 1-22 fragment of C-Type Natriuretic Peptide.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 178 | In Stock |
|
| 5MG | 392 | In Stock |
|
| 10MG | 624 | In Stock |
|
| 25MG | 896 | In Stock |
|
| 50MG | 1197 | In Stock |
|
| 100MG | 1611 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
Biological Information
-
Product NameCNP (1-22), human
-
NoteResearch use only, not for human use.
-
Brief DescriptionC-Type Natriuretic Peptide (CNP) (1-22), human is the 1-22 fragment of C-Type Natriuretic Peptide.
-
DescriptionC-Type Natriuretic Peptide (CNP) (1-22), human is the 1-22 fragment of C-Type Natriuretic Peptide.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number127869-51-6
-
Formula Weight2197.6
-
Molecular FormulaC93H157N27O28S3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 50 mg/mL (22.75 mM)
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
anemarsaponin B
Anemarsaponin B has anti-inflammatory effect in LPS-treated RAW 264.7macrophages, the effect is associated with the inhibition of NF-κB transcriptional activity, possibly via the p38 MAP kinase pathway.
-
Toosendanin
Toosendanin has effects on the growth, cell cycle arrest, induction of apoptosis and the involved signaling pathway in human promyelocytic leukemia HL-6 cells.
-
ICCB280
ICCB280 was capable of inducing differentiation and apoptosis of ATRA-resistant patient blasts strongly signify that the activity of this compound can overcome resistance to other current therapies for AML with an unfavorable prognosis.
Cart
sales@molnova.com